Is nivolumab included in medical insurance? How much does a box cost?

Nivolumab (Nivolumab) is an immune checkpoint inhibitor used to treat a variety of cancers. It activates the patient's own immune response by targeting the PD-1 receptor of the immune system, thereby enhancing the ability to attack cancer cells.

Nivolumab is currently on the market in China and has been included in medical insurance. Patients can purchase it domestically at a price of about four to five thousand yuan. Please consult the local hospital pharmacy for specific prices. The main ones abroad are Turkish original drugs, which cost around more than 2,000 yuan, and have the same ingredients and efficacy as the original drugs on the domestic market.

PD-1 is an immune checkpoint protein that usually regulates immune responses to prevent overactive autoimmune responses. However, cancer cells can exploit the PD-1 pathway to evade immune system attack. The function of nivolumab is to block the binding of PD-1 and its ligand PD-L1, allowing T cells to recognize and attack cancer cells, thus prolonging the patient's survival and improving the therapeutic effect.

Nivolumab has been approved for the treatment of advanced non-small cell lung cancer, melanoma, renal cell carcinoma, Hodgkin lymphoma, head and neck squamous cell carcinoma and other cancers. In many clinical trials, nivolumab has shown significant efficacy, especially in patients who have received other treatments without satisfactory results. It is often used as a single agent or in combination with other drugs to treat advanced or metastatic cancer.

Although nivolumab has brought an important breakthrough in cancer treatment, its use may be accompanied by some adverse reactions, such as fatigue, rash, digestive tract problems, etc. Therefore, patients need to be closely monitored and communicate regularly with their doctor during treatment to ensure that the treatment is safe and effective.